Moscow/Sputnik: The coronavirus vaccine will not be available for children in Russia yet, it has to go through a full cycle of trials on adults first, the director of the Gamaleya Scientific Research Institute of Epidemiology and Microbiology, Alexander Gintsburg, told Sputnik.
Geneva/UNI: WHO Health Emergencies Programme Executive Director Dr Michael Ryan on Monday said that India is playing a leading role in the development of potential vaccine candidate and also producing potential anti-COVID drugs.
New Delhi: The Drugs Controller General of India (DCGI) has given approval to Serum Institute of India, Pune to conduct Phase II+III clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine (COVISHIELD) in India. This will hasten the development of the COVID-19 vaccine.
Mumbai/UNI: Pharma major, Wockhardt on Monday said that it has entered into an agreement with the UK Government to fill finish COVID-19 vaccines.
Washington: A top US vaccine developer has said people will need to wear masks and maintain social distancing norms even after taking COVID-19 vaccine.
Washington/UNI: US President Donald Trump during a press briefing said the United States may provide a vaccine for the novel coronavirus to other countries when it is ready.
Giving humanity yet another hope that a solution will be reached soon, US Biotech major Moderna said its COVID-19 vaccine induced a robust immune response and prevented the coronavirus from replicating in the noses and lungs of monkeys.
Indianapolis (US), Jul 24 (UNI) Drug manufacturers representatives from AstraZeneca, Johnson and Johnson, Merck, Moderna, and Pfizer Daccine have expressed confidence to develop COVID-19 vaccine by either the end of 2020 or beginning of 2021.
Moscow/Sputnik: The UK government said on Monday it had entered partnerships with local developers of coronavirus vaccines and secured early access to over 90 million doses of three different types of vaccines and treatment for priority patients.
New Delhi/IBNS: The human trials of India's first Covid-19 vaccine, COVAXIN, is expected to begin next week, media reports said.
Beijing/Xinhua: China will make its COVID-19 vaccine a global public good when it is ready for application after successful research and clinical trials, a senior Chinese official said Sunday.
New York: In the race to end the coronavirus pandemic, the UN chief reminded a virtual medical conference on Thursday that “a vaccine, by itself, is not enough”.
New York/IBNS: The first COVID-19 vaccine to reach phase 1 clinical trial has been found to be safe, well-tolerated, and able to generate an immune response against SARS-CoV-2 in humans, according to new research published in The Lancet.
New York/IBNS: Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, has announced positive interim clinical data of mRNA-1273, its vaccine candidate against novel coronavirus (SARS-CoV-2), from the Phase 1 study led by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).
New Delhi/IBNS: The Indian Council of Medical Research (ICMR) on Saturday announced to partner with the Bharat Biotech International Limited (BBIL) to develop a fully indigenous vaccine for Covid-19 using the virus strain isolated at ICMR's National Institute of Virology (NIV) in Pune, reports said.